González Reyes J, Santana P, González Robaina I, Cabrera Oliva J, Estévez F, Hernández I, López Blanco F, Quintana Aguiar J, Fanjul L F, Ruiz de Galarreta C M
Departamento de Endocrinología Celular y Molecular, Facultad de Medicina, Universidad de Las Palmas de Gran Canaria, Spain.
J Endocrinol. 1997 Jan;152(1):131-9. doi: 10.1677/joe.0.1520131.
To address a possible role of type 1 and 2A serine/threonine protein phosphatases (PP1 and PP2A) in regulating granulosa cell hormonal responses, we investigated the effects of okadaic acid (OA) on FSH- and cAMP-induced steroidogenesis in these cells. When added alone (0.01-1 nmol/l), the cell-permeant phosphatase inhibitor did not affect progesterone and 3 beta-hydroxysteroid dehydrogenase/delta 5-4 isomerase (3 beta-HSD) enzyme activity, whereas when added with FSH it dose-dependently augmented (minimal effective dose, 0.1 nmol/l) gonadotropin-stimulated steroidogenesis in cultured granulosa cells. A similar stimulatory effect of the toxin was observed in cells cultured for 48 h with the cell-permeant analogue dibutyryl cAMP (1 mmol/l), or when granulosa cells were stimulated with the cAMP-inducing agents cholera toxin (1 microgram/ml), forskolin (15 mumol/l) or 1-methyl-3-isobutyl-xanthine (0.1 mmol/l). The observed effect of OA on FSH-supported granulosa cell steroidogenesis was not a consequence of increased cAMP generation, and time course experiments also revealed that a minimal time period of 12 h was necessary for OA (0.1 and 1 nmol/l) to significantly enhance FSH-induced progesterone and 3 beta-HSD enzyme activity. Since OA also inhibits the dephosphorylation of protein kinase C (PKC) substrates, we also compared the effect of OA and the PKC activator 12-O-tetradecanoylphorbol-13-acetate (TPA) on FSH-induced granulosa cell steroidogenic activity. While activation of the PKC pathway with the tumor promoter TPA (10 nmol/l) inhibited progesterone and cAMP accumulation in FSH-stimulated granulosa cells, treatment with OA augmented steroidogenesis and did not affect gonadotropin-induced cAMP generation. Collectively these results suggest that PP1 and PP2A may be important in regulating the phosphorylation state of proteins implicated in the cAMP-protein kinase A-stimulated steroidogenic activity of these cells.
为了探讨1型和2A型丝氨酸/苏氨酸蛋白磷酸酶(PP1和PP2A)在调节颗粒细胞激素反应中的可能作用,我们研究了冈田酸(OA)对这些细胞中促卵泡激素(FSH)和环磷酸腺苷(cAMP)诱导的类固醇生成的影响。当单独添加(0.01 - 1 nmol/l)时,这种可透过细胞的磷酸酶抑制剂不影响孕酮和3β-羟基类固醇脱氢酶/δ5-4异构酶(3β-HSD)的酶活性,而当与FSH一起添加时,它能剂量依赖性地增强(最小有效剂量为0.1 nmol/l)培养的颗粒细胞中促性腺激素刺激的类固醇生成。在用可透过细胞的类似物二丁酰cAMP(1 mmol/l)培养48小时的细胞中,或当颗粒细胞用cAMP诱导剂霍乱毒素(1 μg/ml)、福斯可林(15 μmol/l)或1-甲基-3-异丁基黄嘌呤(0.1 mmol/l)刺激时,观察到该毒素有类似的刺激作用。OA对FSH支持的颗粒细胞类固醇生成的观察到的作用不是cAMP生成增加的结果,时间进程实验还表明,OA(0.1和1 nmol/l)显著增强FSH诱导的孕酮和3β-HSD酶活性需要至少12小时的最短时间。由于OA也抑制蛋白激酶C(PKC)底物的去磷酸化,我们还比较了OA和PKC激活剂12-O-十四酰佛波醇-13-乙酸酯(TPA)对FSH诱导的颗粒细胞类固醇生成活性的影响。虽然用肿瘤启动子TPA(10 nmol/l)激活PKC途径会抑制FSH刺激的颗粒细胞中孕酮和cAMP的积累,但用OA处理会增强类固醇生成,并且不影响促性腺激素诱导的cAMP生成。这些结果共同表明,PP1和PP2A在调节与这些细胞中cAMP - 蛋白激酶A刺激的类固醇生成活性相关的蛋白质的磷酸化状态方面可能很重要。